EMAIL THIS PAGE TO A FRIEND

Transfusion

The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells.


PMID 24446786

Abstract

The NKG2D receptor, one of the natural killer (NK) cell-activating receptors, is expressed on the surface of CD3+CD8+ T cells, γδ+ T cells, NK cells, NKT cells, and a few CD4+ T cells. We show, for the first time, a critical role for the NKG2D receptor on CD3+CD8+ T cells isolated from myeloma patients, in identifying and killing autologous myeloma cells isolated from the same patients' marrow. We also show that blocking NKG2D using anti-NKG2D reverses the cytotoxicity while blocking HLA-I using antibodies does not have the same effect, showing that the autologous cytotoxicity is NKG2D dependent and major histocompatibility complex (MHC)-I independent. We further confirmed the NKG2D specificity by small interfering RNA (siRNA) down regulation of NKG2D receptor. Using ex vivo expansion methods that enrich for NKG2D+CD3+CD8+ T cells, we investigated whether these ex vivo expanded NKG2D+CD3+CD8+ T cells would recognize and lyse autologous and allogeneic myeloma cells, independent of T-cell receptor or MHC-I expression. Myeloma cell lysis by the NKG2D+CD3+CD8+ T cells correlated with the amount of NKG2D ligand expression. With receptor-ligand interaction, interferon-γ and tumor necrosis factor-α were released. Blocking the NKG2D receptor by using either monoclonal antibodies or siRNAs inhibited the receptor's function and prevented myeloma cell lysis. Clinical trials are ongoing to determine a correlation with the number and function of NKG2D+CD3+CD8+ T cells and clinical outcomes in transplanted myeloma patients, including lymphocyte recovery following transplant and overall survival.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA049948
Anti-ATP8A1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA052935
Anti-ATP8A1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1400126
Anti-HLA-E antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
SAB1401182
Anti-HLA-E antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA031454
Anti-HLA-E antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2107772
Anti-KLRK1 antibody produced in rabbit, affinity isolated antibody
SAB2107773
Anti-KLRK1 antibody produced in rabbit, affinity isolated antibody
HPA006185
Anti-SDC1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1305543 MONOCLONAL ANTI-CD138 antibody produced in mouse, clone 480CT5.4.3, IgG fraction of antiserum, buffered aqueous solution
SAB1305487
MONOCLONAL ANTI-CD138 antibody produced in mouse, clone 480CT5.4.3, crude ascites, buffered aqueous solution
SAB4700743 Monoclonal Anti-CD314 antibody produced in mouse, clone 1D11, purified immunoglobulin, buffered aqueous solution
SAB4700300 Monoclonal Anti-HLA-E antibody produced in mouse, clone MEM-E/08, purified immunoglobulin, buffered aqueous solution
SAB4700301 Monoclonal Anti-HLA-E antibody produced in mouse, clone MEM-E/06, purified immunoglobulin, buffered aqueous solution
SAB4700302 Monoclonal Anti-HLA-E antibody produced in mouse, clone MEM-E/07, purified immunoglobulin, buffered aqueous solution